Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
Development of an Intervention Aimed at Facilitating the Use of Eye Contact in Adults With Autism: A Qualitative Study With Methodological Triangulation
2 other identifiers
observational
18
1 country
1
Brief Summary
The aim of this study is to develop a methodological intervention for adults with autism that will help them reduce problems arising from eye contact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 11, 2025
CompletedStudy Start
First participant enrolled
July 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 3, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 2, 2026
April 11, 2025
April 1, 2025
12 months
March 28, 2025
April 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Developing an intervention using the Intervention Mapping method.
An effective intervention for adults with autism that reduces their difficulty with eye contact problems, with use of Intervention Mapping. The Intervention Mapping protocol consists of six steps, with a number of tasks described for each step. These steps are carried out within focus groups, with two months of time set aside for each step. The six steps of the Intervention Mapping process are: Step 1: Needs assessment Step 2: Change objectives Step 3: Theoretical methods and practical techniques Step 4: Programme design and production Step 5: Program Adoption and Implementation Step 6: Evaluation
Up to 12 months.
Eligibility Criteria
The study population consists of adults with autism, caregivers of adults with autism, and healthcare providers (psychiatrists, psychologists and nursing specialists in psychiatry).
You may qualify if:
- Adults classified with autism, determined according to an internationally recognized classification system.
- Outpatient treatment within a specialized autism center in the Netherlands.
- Able to understand the topics to be discussed.
- Motivation to participate in research.
You may not qualify if:
- No good command of the Dutch language.
- Use of alcohol and/or recreational drugs during the study.
- Mentally too unstable to participate in the study.
- Familiarity with treatment in the VGZ.
- Adults without DSM classification.
- Living in the Netherlands.
- Able to understand the topics to be discussed.
- Motivation to participate in research.
- No good command of the Dutch language.
- Use of alcohol and/or recreational drugs during the study.
- Practicing psychiatrist, clinical psychologist or nurse specialist at an autism expertise center in the Netherlands.
- Living in the Netherlands.
- Motivation to participate in research.
- \- No good command of the Dutch language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
- Dimence Groepcollaborator
Study Sites (1)
Dimence Groep
Deventer, Overijssel, 7416 SB, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nynke Boonstra, Professor
UMC Utrecht
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 11, 2025
Study Start
July 7, 2025
Primary Completion (Estimated)
July 3, 2026
Study Completion (Estimated)
November 2, 2026
Last Updated
April 11, 2025
Record last verified: 2025-04